151 results on '"van Duijnhoven F"'
Search Results
2. Added value of repeat sentinel lymph node biopsy in FDG-PET/CT node-negative patients with ipsilateral breast cancer recurrence
3. Body composition and its association with fatigue in the first 2 years after colorectal cancer diagnosis
4. Impact of prediagnostic smoking and smoking cessation on colorectal cancer prognosis: a meta-analysis of individual patient data from cohorts within the CHANCES consortium
5. Low radiographic muscle density is associated with lower overall and disease-free survival in early-stage colorectal cancer patients
6. Voeding en epidemiologie : December 2016
7. Feasibility of magnetic marker localisation for non-palpable breast cancer
8. Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure
9. Surgical outcomes after neoadjuvant systemic therapy in patients with lobular carcinoma
10. Borderline and malignant phyllodes tumors of the breast: a population-based study of all cases in the Netherlands 1989–2020
11. The successful patient-preference design for the LORD-trial to test whether active surveillance for low-risk Ductal Carcinoma In Situ is safe
12. LBA13 Nivolumab and ipilimumab in early-stage triple negative breast cancer (TNBC) with tumor-infiltrating lymphocytes (TILs): First results from the BELLINI trial
13. Voeding en epidemiologie
14. New Developments in Accelerated Weathering Tests for Back-Contact Modules
15. Body composition and its association with fatigue in the first 2 years after colorectal cancer diagnosis
16. Toward omitting sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with clinically node-negative breast cancer
17. Risk of subsequent in situ and invasive lesions after a primary diagnosis of ductal carcinoma in situ with follow-up time up to 28 years
18. Direct or delayed oncoplastic reconstruction after wide local excision for breast cancer in breast conserving therapy: A single centre cohort study of 252 cases
19. Axillary staging with supine 18F-FDG PET/CT is useful in breast cancer patients undergoing tailored axillary treatment after neoadjuvant systemic therapy according to the MARI protocol
20. Tailored axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer patients is safe: 3-year follow-up of the MARI protocol
21. Women diagnosed with Ductal Carcinoma In Situ (DCIS) and healthcare providers’ views on active surveillance for DCIS. Results from focus groups and in-depth interviews
22. PREVALENCE, CHARACTERISTICS AND ALL-CAUSE MORTALITY RISK OF METABOLICALLY HEALTHY OBESE INDIVUALS: THE EPIC-MORGEN STUDY: 380 accepted poster
23. 201P 70-gene signature to select breast cancer patients for neoadjuvant endocrine treatment
24. Abstract GS5-06: Towards omitting breast surgery in patients with a pathologic complete response after neoadjuvant systemic treatment: interim analysis of the MICRA trial (Minimally Invasive Complete Response Assessment)
25. 52 (PB-052) Poster - Surgical outcomes after neoadjuvant systemic therapy in patients with lobular carcinoma
26. 6 (PB-002) Poster Discussion - Borderline and malignant phyllodes tumors of the breast: a population-based study of all cases in the Netherlands 1989–2020
27. 5 (PB-001) Poster Discussion - The successful patient-preference design for the LORD-trial to test whether active surveillance for low-risk Ductal Carcinoma In Situ is safe
28. General and Abdominal Adiposity and Risk of Death in Europe
29. The essential role of prevention in reducing the cancer burden in Europe:a commentary from Cancer Prevention Europe
30. Adverse effects of radiofrequency ablation of liver tumours in the Netherlands
31. Locoregional Therapies of Liver Metastases in a Rat CC531 Coloncarcinoma Model Results in Increased Resistance to Tumour Rechallenge
32. Toward omitting sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with clinically node-negative breast cancer.
33. European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender.
34. 145 (PB-052) Poster - Preoperative accelerated partial breast irradiation in locally recurrent breast cancer patients.
35. Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations
36. Impact of prediagnostic smoking and smoking cessation on colorectal cancer prognosis: a meta-analysis of individual patient data from cohorts within the CHANCES consortium
37. Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations
38. EU Pancreas: An Integrated European Platform for Pancreas Cancer Research - from Basic Science to Clinical and Public Health Interventions for a Rare Disease
39. Omitting sentinel lymph node biopsy after neoadjuvant systemic therapy in selected breast cancer patients with clinical node-negative disease
40. Breast conserving therapy after neoadjuvant systemic therapy in patients with T3 breast cancer is feasible
41. Abstract OT3-07-01: Update of the randomized, non-inferiority LORD trial testing safety of active surveillance for women with screen-detected low risk ductal carcinoma in situ (EORTC-1401-BCG/BOOG 2014-04, DCIS)
42. Adiposity, mediating biomarkers and risk of colon cancer in the European prospective investigation into cancer and nutrition study
43. Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-results from the EPIC cohort study
44. Plasma and dietary carotenoids and vitamins A, C and E and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition
45. Active and passive cigarette smoking and breast cancer risk: results from the EPIC cohort
46. Pre-diagnostic 25-Hydroxyvitamin D, VDR and CASRPolymorphisms, and Survival in Patients with Colorectal Cancer in WesternEuropean Populations
47. 42. Towards the intraoperative use of diffuse reflectance spectroscopy during breast conserving surgery
48. 37. Selective elimination of axillary surgery after primary systemic treatment in clinically node-positive breast cancer patients by combining PET/CT and the MARI procedure (Marking the Axilla with Radioactive Iodine Seeds)
49. 250. Towards omitting breast cancer surgery in selective patient groups: Assessment of pathologic complete response after primary systemic treatment using multiple biopsies ‘The MICRA trial’
50. 303 (PB-098) - Breast conserving therapy after neoadjuvant systemic therapy in patients with T3 breast cancer is feasible
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.